Period Ending: |
LTM
(Last Twelve Months) |
2023 12-31 |
2022 12-31 |
2021 12-31 |
---|---|---|---|---|
Report Filing | 2024-05-01 | 2023-03-24 | 2022-03-31 | |
Revenue | 0.00 | 0.00 | 0.00 | |
Cost of Revenue | 0.00 | 1.42 | 0.00 | |
Gross Profit | 0.00 | -1.42 | 0.00 | |
Operating Expenses | 1.78 | 0.21 | 0.36 | |
Research & Development | 0.00 | 0.00 | 0.00 | |
Selling, General and Administrative | 1.61 | 1.42 | 0.28 | |
Other Operating Expenses | 0.17 | -1.21 | 0.08 | |
Operating Income | -1.78 | -1.63 | -0.36 | |
Net Non-Operating Interest | 0.00 | 1.49 | 0.01 | |
Interest Income | 0.00 | 1.49 | 0.01 | |
Interest Expense | 0.00 | 0.00 | 0.00 | |
Equity & Other Income/(Expense) | 2.24 | 0.00 | 0.00 | |
Income Before Tax | 0.46 | -0.14 | -0.35 | |
Income Tax Expense | 0.62 | 0.00 | -0.01 | |
Income Attributable to Non-Controlling Interest | 0.00 | 0.00 | 0.00 | |
Net Income | -0.15 | -0.15 | -0.35 | |
Depreciation and Amortization | 1.78 | 1.63 | 0.87 | |
EBITDA | 0.00 | 0.00 | 0.51 | |
Earnings Per Share (EPS) | -0.021 | -0.011 | -0.026 | |
Diluted Earnings Per Share | -0.018 | -0.011 | -0.026 | |
Weighted Average Shares Outstanding | 7.36 | 13.1 | 13.1 | |
Diluted Weighted Average Shares Outstanding | 8.37 | 13.1 | 13.1 |